Physician profile
Robert O Aepli
NPI 1942286513
$2,531.06
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,371 · 2020: $244 · 2021: $323 · 2022: $384 · 2023: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $751.49 | 2019-2021 | |
| Abbvie INC. | $634.82 | 2019-2022 | |
| Aspira Women'S Health INC | $227.99 | 2022 | |
| Merck Sharp & Dohme LLC | $128.19 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $119.52 | 2023 | Austedo |
| Minerva Surgical, INC | $116.51 | 2019-2023 | |
| Evofem Biosciences, INC. | $100.30 | 2021-2022 | |
| Daiichi Sankyo INC. | $96.76 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $60.78 | 2021-2022 | |
| Roche Diagnostics Corporation | $46.67 | 2019 | |
| Therapeuticsmd, INC. | $41.24 | 2019-2022 | |
| Medtronic Vascular, INC. | $21.01 | 2020 | |
| Alydia Health | $18.05 | 2021 | |
| Allergan, INC. | $17.48 | 2020 | |
| Meditrina | $15.87 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $15.13 | 2021 | |
| Lsi Solutions INC | $14.50 | 2020 | |
| Amag Pharmaceuticals, INC. | $14.39 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.73 | 2019 | |
| Coopersurgical, INC. | $13.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.50 | 2021 | |
| Amgen INC. | $13.14 | 2019 | |
| Exeltis, USA INC. | $12.22 | 2022 | |
| Medtronic, INC. | $12.07 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aepli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.